8th of July 2019
"We are proud to announce that the management of Prejex GmbH have concluded an agreement with a US OTC listed company to acquire our IP rights, brand and patents pending. Under the agreement, the US company will initiate production in Germany and intends to be rolling out the first lots of the Prejex medical device in the US market within this year. Prejex GmbH has been engaged to advise on and manage the local German production and quality control procedures. Our management will join the board of the listed entity shortly together with our colleagues from the USA. We are looking forward to quickly capturing a substantial share of the vast North-American medical devices market for needle-free injection devices."
“PREJEX INC, a U.S. corporation acquires the assets of Prejex GmbH” and established operations in New York USA and Berlin Germany”
“PREJEX INC to present at National Investment Bankers Association (NIBA) conference in New York in Jan 2019”
“PREJEX INC closes financing to commercialize novel needle-free injector for painless administration of medicines, biologics, and vaccines”
“PREJEX management hired to roll out commercial sales in the U.S. and other major markets”.